Shared on10 Aug 25Fair value Decreased 7.69%
The reduction in Krishna Institute of Medical Sciences' price target reflects a decline in its future P/E ratio, suggesting lower expected earnings multiples despite stable revenue growth forecasts, resulting in the fair value estimate decreasing from ₹820.62 to ₹757.54. What's in the News Board meeting scheduled to consider and approve unaudited standalone and consolidated financial results for Q1 ended June 30, 2025, and other matters.
Shared on23 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25Fair value Decreased 0.55%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Increased 5.35%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on13 Mar 25Fair value Decreased 15%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.